iodixanol

This page contains recent news articles, when available, and an overview of iodixanol but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Iodixanol unexpectedly linked to higher renal failure rates.( …  -  Dec 15, 2005
NICE, FRANCE -- A study of 77000 Swedish cardiac patients found rates of renal failure were about twice as high following the use of iodixanol, ... Free with registration - Internal Medicine News - AccessMyLibrary.com

… -brain barrier disruption by intracarotid iohexol and iodixanol in...  -  Dec 1, 2008
It was hypothesized that the low osmolality of iodixanol (272 mOsm/kg at 300 mgl/ml) would cause less disruption of the blood-brain barrier than the ... AJNR (subscription)

Iodixanol vs Iopromide Study Abstract Presented at American College...  -  Apr 1, 2008
An abstract of a first-ever 208-person study comparing the renal safety, occurrence of cardiovascular adverse events and diagnostic image quality of the ... Web Services Journal - Web Services Journal

CIN Risk Similar With Iso- and Low-Osmolar Contrast  -  Jul 21, 2008
Severe CIN occurred more frequently in the iodixanol group than than the iomeprol group (6.2% vs. 3.7%), but the difference was not statistically ... Renal and Urology News

Guerbet - Another Proof That There is No Difference Between Low- …  -  Oct 27, 2006
They were randomized to receive either Ioxaglate (74 patients) or Iodixanol (71 patients) during their procedures. The two groups had similar baseline ... RedOrbit

Risk of contrast-induced nephropathy in patients with normal renal …  -  Jan 12, 2007
Of the 221 patients recruited, 105 were randomized to receive iodixanol and 116 to receive iopromide. There were no major differences between the two groups ... Nature.com

Article: Iodixanol unexpectedly linked to higher renal failure...  -  Dec 15, 2005
Iodixanol unexpectedly linked to higher renal failure rates.(Cardiovascular Medicine) ... find Internal Medicine News articles. NICE, FRANCE -- A study of ... Pay-Per-View - Internal Medicine News - HighBeam Research

Product Briefs  -  Nov 2, 2006
...marketed by Bracco in the US, and Visipaque-320 (iodixanol injection), ... injection of equi-iodine doses of iopamidol-370 and iodixanol-320, ... Free with registration - Medical Device Week - AccessMyLibrary.com

Iso-osmolar X-ray dye falters in PCI study  -  Apr 1, 2008
Some earlier studies have shown that iodixanol (Visipaque) reduces the risk of ... Iodixanol, a contrast agent that has approximately the same osmolarity as ... Genetic Engineering News - Genetic Engineering News (press release)

Iso-osmolar X-ray dye falters in PCI research  -  Apr 3, 2008
Some earlier studies have shown that iodixanol (Visipaque) reduces the risk of ... Iodixanol, a contrast agent that has approximately the same osmolarity as ... Science Centric

In contrast with 1990s, media prices set to rise.  -  May 1, 2005
Now, another technology has emerged, the iodixanol-based line exemplified by ... In clinical trials, iodixanol was found to decrease adverse events compared ... $4.95 - Hospital Materials Management - ECNext

Nephrotoxicity of low-osmolality versus iso-osmolality contrast...  -  Jan 19, 2005
Recent data support that iodixanol, an iso-osmolality contrast agent, is less nephrotoxic than low-osmolality contrast agents when hydration is the only ... Nature.com

Box 1 : Detergent resistance as a tool in membrane research : Nature ...  -  Aug 30, 2007
...(Optional) Adjust the buffer concentration to 40% (w/v) iodixanol by adding 460 ... Adjust sample composition to 40% iodixanol (wt/vol) by mixing with 400 l ... Nature.com

Visipaque Linked To Lower Incidence Of Contrast-Induced Nephropathy …  -  Nov 24, 2008
The conclusion of the study indicates that isosmolar CM iodixanol appears to be ... A randomized study of 1276 patients undergoing PCI using iodixanol ... Medical News Today - Medical News Today (press release)

Study shows GE Healthcare's VisipaqueTM Associated with Lower …  -  Nov 21, 2008
The conclusion of the study indicates that isosmolar CM iodixanol appears to be ... A randomized study of 1276 patients undergoing PCI using iodixanol ... International Business Times

Low-Osmolar Contrast Agent Is Safer For the Kidneys  -  Jan 1, 2007
Of these, 45485 received the iso-osmolar contrast medium iodixanol and 12440 ... Hospitals that switched from ioxaglate to iodixanol had a doubling in ... Renal and Urology News

The Latest Head-to-Head Clinical Study Comparing the Risk of CIN …  -  Oct 31, 2006
Despite differences in osmolality between these two agents (iopamidol-370 796 mOms/kg versus iodixanol-320 290 mOms/kg) the IMPACT study did not show ... Free with registration - Business Wire - AccessMyLibrary.com

… Creatinine Levels after Contrast Media Administration with Iodixano...  -  Jul 16, 2008
GE Healthcare's iodixanol, an isosmolar contrast medium, ... Sixty-one patients were administered iodixanol, while 56 were administered iopromide. ... Genetic Engineering News - Genetic Engineering News (press release)

Distribution of brevetoxin (PbTx-3) in mouse plasma: association with...  -  Nov 1, 2005
We added 2 mL of 60% iodixanol {5,5'-[(2-hydroxy-1-3 propanediyl)-bis(acetylamino)] bis [N,N'-bis (2,3-dihydroxypropyl-2,4,6-triiodo-1 ... Free with registration - Environmental Health Perspectives - AccessMyLibrary.com

CONTRAST Study: To What Extent Do High-Risk Patients Benefit From …  -  Jun 9, 2008
The CIN rate in the IODIXANOL patients was 20% lower than the CIN rate in the IOMEPROL arm of the study (22.2% vs. 27.7%). The difference was, however, ... Medical News Today - Medical News Today (press release)

Guerbet - Another Proof That There is no Difference Between Low- …  -  Oct 27, 2007
They were randomized to receive either Ioxaglate (74 patients) or Iodixanol (71 patients) during their procedures. The two groups had similar baseline ... DG News

Press Release: Guerbet - Another Proof That There is no Difference …  -  Oct 27, 2006
They were randomized to receive either Ioxaglate (74 patients) or Iodixanol (71 patients) during their procedures. The two groups had similar baseline ... Pay-Per-View - PR Newswire - HighBeam Research

REMEDIAL: a role for sodium bicarbonate in the prevention of contrast...  -  Mar 30, 2007
The primary end point was occurrence of CIN, as determined by a 25% increase in serum creatinine from baseline 48 h after the administration of iodixanol, ... Nature.com

Molecular Therapy - Abstract of article: 91. Universal purification...  -  Feb 1, 2006
These helper vectors were then used to produce recombinant eGFP virus which were initially purified by either cesium chloride or iodixanol gradients ... Nature.com

Commentary on article: strategies for prevention of the acute kidney...  -  Mar 1, 2008
This study showed no advantage to the use of iso-osmolar iodixanol over the low osmolar agent iopamidol, even in patients with both CKD and diabetes. ... Pay-Per-View - Nephrology Nursing Journal - HighBeam Research

COMUNICADO: Guerbet: Nuevos datos sobre la prevención de la …  -  Oct 27, 2006
Los resultados de un reciente ensayo clínico demostraron que los agentes de contraste Hexabrix(R) (Ioxaglato) y Visipaque(R) (Iodixanol) no fueron ... elEconomista.es

Vectors; Findings from the United States and Netherlands advance …  -  Oct 5, 2006
Thus, the iodixanol-based method can be used not only to improve the production of RGD-modified adenovectors but also to purify adenovectors with or without ... Pay-Per-View - Gene Therapy Weekly - Factiva, from Dow Jones

Imaging; Risk of contrast-induced nephropathy is highest for iohexol  -  Sep 29, 2006
Keywords: Burlington, Vermont, United States, Imaging, Contrast Media, Adverse Drug Effect, Contrast-Induced Nephropathy, Iodixanol, Iohexol, Kidney Damage, ... Pay-Per-View - Drug Week - Factiva, from Dow Jones

Product Briefs.  -  Dec 1, 2006
...marketed by Bracco in the U.S., and Visipaque-320 (iodixanol injection), ... injection of equi-iodine doses of iopamidol-370 and iodixanol-320, ... $9.94 - Biomedical Business & Technology - Alacra Store

AAV1 Mediated Co-expression of Formylglycine-Generating Enzyme and …  -  Jan 5, 2006
Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for ... Nature.com

The novel cargo Alcadein induces vesicle association of kinesin-1...  -  Mar 1, 2007
The post-nuclear supernatant of adult mouse brains was fractionated by 0–28% iodixanol density gradient centrifugation (Araki et al, 2003). ... Nature.com

Article: Life sciences sector holds promise for future job growth, …  -  Jul 20, 2007
Chitnis, University of Rhode Island Kingston, Dept. of Biomedical ... Keywords: United States, Life Sciences, Iodixanol, Pharmaceuticals ... ... Pay-Per-View - Providence Journal - HighBeam Research

Article: STRIKEOUTS Harang, Cin ... ... - The Washington Post | …  -  Apr 23, 2008
...words ... ... suggest that contrast-induced nephropathy (CIN) has a causal role in the development of ... iopamidol and iodixanol--in preventing CIN. ... Pay-Per-View - Washington Post - HighBeam Research

GE Healthcare ties up with Manipal Health  -  Jun 30, 2006
According to Mr Peters, the first studies will be on the agent Visipaque (iodixanol) that GE launched in 1996 and used in X-ray and CT scans. ... Hindu Business Line

Contrast nephropathy: are short-term outcome measures adequate for …  -  Jul 11, 2008
Weisbord et al. evaluated the adverse renal effects of iodinated contrast agents, primarily the iso-osmolar agent iodixanol, in stable patients who ... Nature.com

Can 32-detector-row CT exclude significant stenoses in coronary...  -  Jun 7, 2006
Kabushiki Kaisha Toshiba TA, Kanagawa-ken, Japan) after injection of a 120 ml bolus of iodixanol. All four main coronary arteries—including first order ... Nature.com

Visualizing a healthier world.(TOP 200 PACKAGERS: MEDICAL: #2: GE …  -  Jul 1, 2005
From a packaging perspective, last July the company added to its Omnipaque[TM] (iohexol) and Visipaque (iodixanol) product packaging portfolios with the ... $4.95 - Food & Drug Packaging - ECNext

Prospective electrocardiogram-gating: a new direction for CT coronary...  -  Feb 21, 2008
All patients underwent 64-slice CTCA with prospective ECG-gating according to an established protocol, and the contrast agent iodixanol was used (80 ml at 5 ... Nature.com

MPV17 encodes an inner mitochondrial membrane protein and is …  -  Apr 2, 2006
...and two 100000g iodixanol gradient fractions separating 'light' mitochondria and microsomes (lane 3) from purified peroxisomes (lane 4). ... Nature.com

Gadolinium-containing contrast materials  -  Oct 30, 2007
...non-ionic I-CM (eg iodixanol) for the respective X-ray studies or CTs. Nonetheless, the absolute numbers of I-CM induced ARF apparently have not fallen. ... European Hospital

Article: U. Rhode Island's lyme disease, environmental research to...  -  Dec 7, 2005
Chitnis, University of Rhode Island Kingston, Dept. of Biomedical ... Keywords: United States, Life Sciences, Iodixanol, Pharmaceuticals ... ... Pay-Per-View - University Wire - HighBeam Research

Article: Contrast media focus of Novation-GE agreement.(GE Healthcare)...  -  Apr 1, 2005
Business Wire; November 21, 2008 ; 700+ words ... ... image quality of GE Healthcare's isosmolar contrast media (CM) iodixanol ... the appropriate contrast ... Pay-Per-View - Hospital Materials Management - HighBeam Research

What interventions reduce the risk of contrast nephropathy for high...  -  Apr 1, 2005
...(7) Iso-osmolar B Varying volumes of iodixanol, an iso-osmolar contast media contrast medium, were used rather than iohexol, a low osmolar contrast medium. ... $4.95 - Journal of Family Practice - ECNext

Article: Britney's latest head line.(Features) - Huddersfield Daily...  -  Feb 21, 2007
...and Visipaque([TM320 (iodixanol injection), marketed by GE Healthcare in the United States, in renally Im paired Pa tients undergoing C omputed ... Pay-Per-View - Huddersfield Daily Examiner - HighBeam Research

Article: Cervical Ca guidelines focus on special groups.(Women's...  -  Nov 1, 2007
...words ... ... suggest that contrast-induced nephropathy (CIN) has a causal role in the development of ... iopamidol and iodixanol--in preventing CIN. ... Pay-Per-View - Internal Medicine News - HighBeam Research

GE Healthcare dan Sistem Kesehatan Manipal Lakukan Kajian Klinis …  -  Jun 30, 2006
Kajian pertama akan berfokus pada Visipaque (iodixanol) obat pelawan isosmolar yang diluncurkan di seluruh dunia oleh GE Healthcare pada tahun 1996. ... ANTARA

Article: Docs in dark on contrast nephropathy.(Nephrology) - Internal...  -  Sep 15, 2007
...words ... ... suggest that contrast-induced nephropathy (CIN) has a causal role in the development of ... iopamidol and iodixanol--in preventing CIN. ... Pay-Per-View - Internal Medicine News - HighBeam Research

Prevention of contrast-induced nephropathy: the rational use of...  -  Jul 1, 2007
Low osmolar, non-ionic contrast media, iohexol, was compared with the iso-osmolar, non-ionic media, iodixanol, and investigators found that the iso-osmolar ... $4.95 - Nephrology Nursing Journal - ECNext

N -Acetylcysteine is Renoprotective  -  May 5, 2008
Hydration and iso-osmolar or low-osmolar contrast agents such as iodixanol are all associated with a decreased incidence of contrast-induced nephropathy in ... Renal and Urology News

The Path to Clinical Protocols  -  May 1, 2006
The Minnesota group used this approach clinically, together with nonionic purification gradients for islet purification (iodixanol); the routine use of ... Scientist

Nanoparticle Reports on Drug Delivery to Breast Tumors, Predicts …  -  Nov 20, 2008
To create their nanoparticle, the investigators first prepared a highly concentrated solution of the x-ray contrast agent iodixanol and then added two ... Nanotechnology News - Nanotechnology News (press release)

Inexpensive Drug Found Best for Renoprotection from Contrast Agent  -  Feb 26, 2008
Saline hydration and the introduction of iso-osmolar or low-osmolar contrast agents such as iodixanol have reduced the rate of contrast-induced nephropathy, ... MedPage Today

The Insider: Walkers can't do enough good work, VC lawyer can't get …  -  Nov 6, 2006
Text: Results from a recent clinical trial demonstrated that contrast agents Hexabrix(R) (Ioxaglate) and Visipaque(R) (Iodixanol) were no different in ... nwsource.com

Nanoparticle Reports on Drug Delivery to Breast Tumors, Predicts …  -  Nov 30, 2008
To create their nanoparticle, the investigators first prepared a highly concentrated solution of the x-ray contrast agent iodixanol and then added two ... Nanotechwire.com

Getting the most out of carbon nanotubes  -  May 5, 2008
They put surfactant-coated nanotubes into test tubes and added layers of various concentrations of iodixanol solution to create a density gradient. ... Photonics.com

Hybrid Imaging, Part 1: Daybreak for a New Radiology  -  Jan 20, 2006
IV contrast CT scans that were obtained at 30 seconds, 70 seconds, and 180 seconds after IV contrast administration (150 mL iodixanol, 320 mg/mL). ... Medscape

GE opens development centre in India to study medical diagnostic …  -  Jul 13, 2006
The first studies will focus on Visipaque (iodixanol) an isosmolar contrast agent that was launched globally by GE Healthcare in 1996. ... MTBeurope

Georgia Code - 16-13-71. (a) A "dangerous drug" means any drug other ...  -  Aug 4, 2005
...(481) Iodine solution, Strong oral; (482) Iodipamide; (482.5) Iodixanol; (483) Iodized oil; (484) Iodobenzoic acid — See exceptions; (485) Iodobrassid; ... Pay-Per-View - Georgia Code - Loislaw

HIV/AIDS; New research from the United States in the area of HIV/AIDS...  -  May 2, 2006
..."We also demonstrate that different properties of sucrose and iodixanol membrane flotation gradients may explain some discrepancies regarding Gag-raft ... Pay-Per-View - Virus Weekly - Factiva, from Dow Jones

HIV/AIDS; New research from the United States in the area of HIV/AIDS...  -  May 5, 2006
..."We also demonstrate that different properties of sucrose and iodixanol membrane flotation gradients may explain some discrepancies regarding Gag-raft ... Pay-Per-View - Science Letter - Factiva, from Dow Jones

HIV/AIDS Pathogenesis; New findings in HIV/AIDS pathogenesis …  -  Apr 24, 2006
..."We also demonstrate that different properties of sucrose and iodixanol membrane flotation gradients may explain some discrepancies regarding Gag-raft ... Pay-Per-View - AIDS Weekly - Factiva, from Dow Jones

HIV/AIDS Pathogenesis; New findings in HIV/AIDS pathogenesis …  -  Apr 27, 2006
..."We also demonstrate that different properties of sucrose and iodixanol membrane flotation gradients may explain some discrepancies regarding Gag-raft ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones

Imaging; Findings advance knowledge in imaging research  -  Mar 28, 2006
The protocol for contrast material administration was 100 ml of Iodixanol 320 mgI/ml at 4 ml/s and the scan delay was defined with a bolus tracking ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

HIV/AIDS Pathogenesis; Association of HIV-1 gag with membrane does …  -  Jan 2, 2006
..."We also demonstrate that different properties of sucrose and iodixanol membrane flotation gradients may explain some discrepancies regarding Gag-raft ... Pay-Per-View - AIDS Weekly - Factiva, from Dow Jones

Imaging; Increasing intravascular enhancement improves diagnostic …  -  Jan 3, 2006
The protocol for contrast material administration was 100 ml of Iodixanol 320 mgI/ml at 4 ml/s and the scan delay was defined with a bolus tracking ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Article: Physicians debate conservative versus aggressive treatment...  -  Jul 1, 2006
...words ... ... suggest that contrast-induced nephropathy (CIN) has a causal role in the development of ... iopamidol and iodixanol--in preventing CIN. ... Pay-Per-View - Family Practice News - HighBeam Research

Press Release: Nventa Announces Positive Interim Immunological Data …  -  Mar 26, 2008
...words ... ... suggest that contrast-induced nephropathy (CIN) has a causal role in the development of ... iopamidol and iodixanol--in preventing CIN. ... Pay-Per-View - PR Newswire - HighBeam Research

Overview of Divisional Programs.(Table)(Calendar) | Article from...  -  Jan 1, 2008
GELATIN SUSPENDED CARBON NANOTUBE ALIGNMENT AND DIFFERENTIATION UTILIZING IODIXANOL 10. THEORETICAL STUDY OF THE ADSORPTION OF ORGANOPHOSPHORUS COMPOUNDS ON ... Pay-Per-View - Journal of the Mississippi Academy of... - HighBeam Research

ë?°ì?¼ë¦¬ê²½ì œ  -  Jun 4, 2008
...�번� �용� 논문� 'Renal Toxicity Evaluation and Comparison Between Visipaqueâ (Iodixanol) and Hexabrixâ (Ioxaglate) in Patients With Renal Insufficiency ... ��리경제

Le colorant pour rayon-X Iso-osmolaire bat de l'ail dans l'étude sur...  -  May 15, 2008
Certaines études antérieures avaient révélé que l'iodixanol (Visipaque) réduit le risque de lésions rénales lorsque des doses modérées – ou milieu de ... InformationHospitaliere.com

Article: Cystatin C predicts CV events.(CLINICAL CAPSULES)(Brief …  -  Jul 15, 2005
Article: Fewer CV events, less nephropathy with iodixanol vs ... Reactions Weekly; November 29, 2008 ; 410 words ... ... associated with a significantly ... Pay-Per-View - Internal Medicine News - HighBeam Research





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy